BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20218791)

  • 21. Predictors of metabolic syndrome in Asian north Indians with newly detected type 2 diabetes.
    Dhanaraj E; Bhansali A; Jaggi S; Dutta P; Jain S; Tiwari P; Ramarao P
    Indian J Med Res; 2009 May; 129(5):506-14. PubMed ID: 19675377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes.
    Kompoti M; Mariolis A; Alevizos A; Kyrazis I; Protopsaltis I; Dimou E; Lentzas I; Levisianou D; Gova A; Melidonis A
    Cardiovasc Diabetol; 2006 Oct; 5():21. PubMed ID: 17020601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome in connection with BMI in young Finnish male adults.
    Mikkola I; Keinänen-Kiukaanniemi S; Laakso M; Jokelainen J; Härkönen P; Meyer-Rochow VB; Juuti AK; Peitso A; Timonen M
    Diabetes Res Clin Pract; 2007 Jun; 76(3):404-9. PubMed ID: 17064807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and heritability of clusters for diagnostic components of metabolic syndrome: the Oman family study.
    Lopez-Alvarenga JC; Solís-Herrera C; Kent JW; Jaju D; Albarwani S; Al Yahyahee S; Hassan MO; Bayoumi R; Comuzzie AG
    Metab Syndr Relat Disord; 2008 Jun; 6(2):129-35. PubMed ID: 18484902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study.
    Mattsson N; Rönnemaa T; Juonala M; Viikari JS; Raitakari OT
    J Intern Med; 2007 Feb; 261(2):159-69. PubMed ID: 17241181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes.
    Marchesini G; Forlani G; Cerrelli F; Manini R; Natale S; Baraldi L; Ermini G; Savorani G; Zocchi D; Melchionda N
    Diabet Med; 2004 Apr; 21(4):383-7. PubMed ID: 15049944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in Singapore.
    Nurjono M; Lee J
    Early Interv Psychiatry; 2013 May; 7(2):205-9. PubMed ID: 22747854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse associations between muscle mass, strength, and the metabolic syndrome.
    Atlantis E; Martin SA; Haren MT; Taylor AW; Wittert GA;
    Metabolism; 2009 Jul; 58(7):1013-22. PubMed ID: 19394973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of the metabolic syndrome among female Kuwaiti adolescents using two different criteria.
    Al-Isa A; Akanji AO; Thalib L
    Br J Nutr; 2010 Jan; 103(1):77-81. PubMed ID: 19664298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction.
    Corona G; Mannucci E; Petrone L; Schulman C; Balercia G; Fisher AD; Chiarini V; Forti G; Maggi M
    J Sex Med; 2007 May; 4(3):789-796. PubMed ID: 17498109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (Boloor Diabetes Study) population of Mangalore.
    Pemminati S; Prabha Adhikari MR; Pathak R; Pai MR
    J Assoc Physicians India; 2010 Nov; 58():674-7. PubMed ID: 21510460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects.
    Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R
    Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.
    Saltevo J; Vanhala M; Kautiainen H; Kumpusalo E; Laakso M
    Diabet Med; 2008 Jun; 25(6):747-50. PubMed ID: 18435780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.